Position in VERU
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$106,080
+$3,360 QoQ
Shares Held
48,000
0.0% QoQ
Ownership
0.299%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VERU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BLAIR WILLIAM & CO/IL holds $126,358,113 across 56 Biotechnology names. VERU ranks #39 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
864,329 | $45,169,833 | |
| 2 | ARGX |
Argenx SE
|
22,407 | $16,362,711 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
371,119 | $12,076,212 | |
| 4 | EXEL |
Exelixis, Inc.
|
193,238 | $8,287,977 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,541 | $7,386,218 | |
| 6 | SLDB |
Solid Biosciences Inc.
|
651,216 | $4,688,755 | |
| 7 | NGNE |
Neurogene Inc.
|
168,218 | $3,391,274 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,430 | $3,120,104 |
All Filings in VERU
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $106,080 | 48,000 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $102,720 | 48,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $144,400 | 38,000 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||